VAERS reports by lot

GSK DTaP/Tdap lot L5229: VAERS reports

46 VAERS reports list lot L5229 as a GSK DTaP/Tdap vaccine, received between 2025-02-18 and 2026-04-22. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
46
Reports
0%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2328%
Neurological1620%
General / Systemic (non-local)1417%
Musculoskeletal1215%
Respiratory56%
Cardiac / Cardiovascular45%
Gastrointestinal34%
Psychiatric / Neuropsychiatric34%
Allergic / Anaphylactic11%
Dermatological (non-injection-site)11%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Florida20
Georgia5
Texas3
Michigan3
Minnesota2
Tennessee2
New York2
Kansas1
Colorado1
Nevada1
Pennsylvania1
Wisconsin1

Reports by month received

MonthReportsBar
2025-023
2025-0321
2025-049
2025-054
2025-064
2025-074
2026-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK DTaP/Tdap lots (A–Z): JF7DM · K4979 · K5F5R · LP2G2 · LS444 · MF9EA

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.